| Literature DB >> 31294102 |
Gursatej Gandhi1, R Sharma1, Gurpreet Kaur1.
Abstract
The beneficial effects of physical exercise regularly for overall well being, or for recreational or professional purposes are widely accepted in clinical practice and have from time immemorial been the reasons for performing traditional sports. On the contrary, there is also evidence implying increased oxidative stress and genetic damage from intensive exercising. Depending on the intensity, time, frequency and characteristics of exercises, there can be differential induction of oxidative stress and provocation of oxidation of cellular macromolecules (including DNA) and cellular dysfunction which can likely accumulate with age, physical attributes and increase the susceptibility to disease on one hand, while stimulating cell signalling pathways leading to cell adaptation and improved resistance to stress, on the other. In order to observe if continuous sports activities as in Kho Kho increase oxidation capacity, which can also provoke oxidation of cellular macromolecules, the effects on oxidative/antioxidant changes and DNA damage in professional Kho Kho players modulated by individual genetic differences were assessed. Kho Kho, a traditional Indian game of 'Tag', is an all-time favourite which requires endurance, agility and strength. Healthy Kho Kho players (20.27 ± 0.28 y; sports age 6.78 ± 0.52 y) and controls (20.90 ± 0.45 y) were matched for age, gender, BMI, VO2 max (maximal oxygen uptake), frequency of GSTT1 (present/null), M1 (present/null), SOD2 (C199T) polymorphisms but differed for variant allele frequencies of GSTP1 (A313G) and SOD2 (C47T). Players compared to controls had significantly increased levels of DNA damage (1.8x, 44.66 ± 1.68 vs. 23.85 ± 1.79 μm, p = 0.000), lipid (MDA) peroxidation (2x, 1.72 ± 0.06 vs. 0.83 ± 0.16 μmol/l, p = 0.000) and total antioxidant capacity (1.09x, 1.69 ± 0.06 vs. 1.11 ± 0.03 mmol Trolox equivalent/l, p = 0.000) but with no differences for SOD activity (94.99 ± 2.42 vs. 93.36 ± 2.54 U/ml, p = 0.935). These results suggest that the players have increased genetic damage and oxidative stress probably from the intense physical activity in the absence of other exposure(s) as other attributes were comparable in the study group. The players may therefore be at increased risk for susceptibility to cancer, various diseases and precocious age-related changes and should be sensitized to health risks related to regular intensive physical exercise.Entities:
Keywords: Biochemistry; Cancer research; Genetics; Molecular biology
Year: 2019 PMID: 31294102 PMCID: PMC6595184 DOI: 10.1016/j.heliyon.2019.e01928
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Demographic characteristics of Kho Kho players and the controls.
| Study Characteristics | Controls (n = 10) (%) | P values | |||||
|---|---|---|---|---|---|---|---|
| Gender | Males | 11 (61.11) | 08 (80.00) | 0.546 | |||
| Females | 7 (38.88) | 02 (20.00) | |||||
| Age (y) | 20.27 ± 0.28 | 20.90 ± 0.45 | 0.239 | ||||
| Warm-up time (min) | 23.33 ± 1.51 | – | – | ||||
| Daily training sessions during camps (h) | 4.33 ± 0.38 | ||||||
| Time-since-exercising/Sport Age (y) | 6.78 ± 0.52 | ||||||
| Professionally active sport age (range) | 3–11 y | ||||||
| Underweight (<18.0) | – | – | 0.516 | ||||
| Normal (18.00–22.90) | 15 (83.33) | 09 (90.00) | |||||
| Overweight (23.00–24.90) | 01 (5.55) | 01 (10.00) | |||||
| Obese (>25.00) | 02 (11.11) | – | |||||
| 21.49 ± 0.58 | 20.78 ± 0.57 | 0.433 | |||||
| Non-obese | Females | <80 | 7 (38.88) | 02 (20.00) | 0.182(f) | ||
| Males | <85 | 11 (61.11) | 08 (80.00) | ||||
| Obese | Females | ≥80 | – | – | |||
| Males | ≥85 | ||||||
| 32.69 ± 0.57 | 80.77 ± 2.74 | ||||||
| Non-obese | Females | <0.81 | – | – | 0.182(f), | ||
| Males | <0.88 | 01 (10.00) | |||||
| Obese | Females | ≥0.81 | 7 (38.88) | 02 (20.00) | |||
| Males | ≥0.88 | 11 (61.11) | 07 (70.00) | ||||
| 0.89 ± 0.01 | 0.93 ± 0.02 | 0.164 | |||||
| Fair | Females | 36–39 | – | 02 (20.00) | – | ||
| Males | 42–45 | – | – | ||||
| Good | Females | 40–43 | 05 (27.77) | – | 0.327(t) | ||
| Males | 46–50 | – | 01 (10.00) | ||||
| Excellent | Females | 44–49 | 01 (5.55) | – | 0.723(m); | ||
| Males | 51–55 | 03 (16.66) | 05 (50.00) | ||||
| Superior | Females | >49 | 01 (5.55) | – | 0.11(m); | ||
| Males | >55 | 08 (44.44) | 02 (20.00) | ||||
| 54.37 ± 2.21 | 50.37 ± 2.06 | 0.243 | |||||
| Present | 11 (61.11) | 02 (20.00) | 0.119 | ||||
| Null | 08 (44.44) | 08 (80.00) | |||||
| Present | 11 (61.11) | 06 (60.00) | 0.774 | ||||
| Null | 08 (44.44) | 04 (40.00) | |||||
| AA | 18 (100.00) | 05 (50.00) | |||||
| AG | – | 05 (50.00) | |||||
| GG | – | – | |||||
| A | 36 (100.00) | 20 (75.00) | |||||
| G | – | 05 (25.00) | |||||
| CC | 05 (27.77) | 07 (70.00) | |||||
| CT | 04 (22.22) | 03 (30.00) | |||||
| TT | 09 (50.00) | – | |||||
| C | 14 (38.88) | 17 (85.00) | |||||
| T | 22 (61.11) | 03 (15.00) | |||||
| CC | 18 (100.00) | 10 (100.00) | 0.185 | ||||
| C | 36 (100.00) | 36 (100.00) | |||||
p values in bold are statistically significant (p < 0.05); VO2 max - maximal oxygen uptake; m - males, f - females, t - total.
[19].
[20].
[22].
Gender stratification for the assessed parameters.
| Controls | P value (Players vs Controls) | |||||||
|---|---|---|---|---|---|---|---|---|
| Males (n = 11) | Females (n = 07) | Total | Males (n = 8) | Females (n = 2) | Total | |||
| Trypan-Blue Dye Exclusion Test | Cell Viability (%) | 90.38 | 85.92 | 88.15 | 87.90 | 92.14 | 90.02 | – |
| SCGE Assay | Damage Frequency (AU) | 85.8***1 ± 4.95 | 95.28 ± 2.35 | 89.50 ± 3.29 | 72.87 ± 2.96 | 73.50 ± 3.50 | 73.00 ± 2.39 | |
| Mean DNA migration length (μm) | 43.17*** ± 1.55 | 45.78 ± 0.99 | 44.66 ± 1.68 | 25.38 ± 1.21 | 22.14 ± 1.32 | 23.85 ± 1.79 | ||
| Total Antioxidant Levels (mmol Trolox eq/l) | 1.69*** ± 0.06 | 1.53*** ± 0.14 | 1.63*** ± 0.06 | 1.09 ± 0.04 | 1.19 ± 0.04 | 1.11 ± 0.03 | ||
| Malondialdehyde (MDA) Levels (μmol/l) | 1.72*** ± 0.06 | 1.63*** ± 0.08 | 1.69*** ± 0.05 | 0.66 ± 0.15 | 1.48 ± 0.09 | 0.83 ± 0.16 | ||
| Superoxide Dismutase (SOD) Activity (U/ml) | 94.99 ± 2.42 | 90.09 ± 3.82 | 93.08 ± 2.11 | 93.34 ± 1.71 | 91.11 ± 0.90 | 93.36 ± 2.54 | 0.935 | |
p values in bold are statistically significant (p < 0.05).
***very highly significant (p = 0.000).
p = 0.03.
Genetic Damage, SOD Activity, TAC and MDA Levels Stratified for VO2 max Categories and Molecular Genotypes of GST and SOD2.
| VO2 max Categories and Molecular Genotypes | Controls | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Damage Frequency (AU) | Mean DNA migration length (μm) | Superoxide Dismutase (SOD) activity (U/ml) | Total Antioxidant Capacity (TAC) (mmol Trolox eq/l) | Malondialdehyde (MDA) Levels (μmol/l) | Number | Damage Frequency (AU) | Mean DNA migration length (μm) | Superoxide Dismutase (SOD) activity (U/ml) | Total Antioxidant Capacity (TAC) (mmol Trolox eq/l) | Malondialdehyde (MDA) Levels (μmol/l) | ||
| Fair | – | 02 | 73.50 ± 3.50 | 22.89 ± 2.67 | 91.11 ± 0.90 | 1.19 ± 0.04 | 1.48 ± 0.09 | ||||||
| Good | 05 | 96.60*** ± 2.92 | 40.25 ± 0.36a | 92.36 ± 4.86 | 1.78 ± 0.09 | 1.65 ± 0.11 | 01 | 66.00 ± 0.00 | 21.33 ± 0.00 | 99.32*** ± 0.00 | 1.15 ± 0.00 | 0.60 ± 0.00 | |
| Excellent | 04 | 86.50*** ± 4.36 | 44.67 ± 1.70 | 95.11* ± 4.13 | 1.62 ± 0.12 | 1.73 ± 0.07 | 05 | 75.40 ± 4.41 | 24.08 ± 1.11 | 93.74 ± 1.19 | 1.12 ± 0.05 | 0.55 ± 0.22 | |
| Superior | 09 | 86.88*** ± 5.97 | 47.09 ± 1.26a | 92.43*** ± 3.03 | 1.54 ± 0.11 | 1.68 ± 0.07 | 02 | 70.00 ± 2.00 | 23.76 ± 0.71 | 89.37 ± 5.83 | 0.98 ± 0.01 | 0.97 ± 0.07 | |
| Present | 11 | 87.72** ± 4.96 | 45.60*** ± 1.35 | 92.94 ± 2.94 | 1.67* ± 0.10 | 1.63* ± 0.07 | 02 | 81.00 ± 3.00 | 24.16 ± 1.62 | 91.78 ± 1.44 | 1.18 ± 0.00 | 0.68 ± 0.65 | |
| Null | 07 | 92.28*** ± 3.52 | 43.15*** ± 1.33 | 93.30 ± 3.10 | 1.55** ± 0.04 | 1.77*** ± 0.05 | 08 | 71.00 ± 2.46 | 23.34 ± 0.85 | 93.18 ± 1.72 | 1.09 ± 0.04 | 0.86 ± 0.15 | |
| Present | 11 | 87.72*** ± 4.96 | 45.60 ± 1.35 | 92.94 ± 2.94 | 1.67 ± 0.10 | 1.63 ± 0.07 | 06 | 73.66 ± 3.01 | 23.53 ± 1.06 | 94.20** ± 1.48 | 1.14 ± 0.03 | 0.84 ± 0.21 | |
| Null | 07 | 92.28*** ± 3.52 | 43.15 ± 1.33 | 93.30* ± 3.10 | 1.55 ± 0.04 | 1.77 ± 0.05 | 04 | 72.00 ± 4.45 | 23.45 ± 1.06 | 90.93 ± 2.61 | 1.06 ± 0.07 | 0.79 ± 0.29 | |
| 11 | 87.72** ± 4.96 | 45.60 ± 1.35 | 92.94 ± 2.94 | 1.67* ± 0.10 | 1.63 ± 0.07 | 02 | 81.00 ± 3.00 | 24.16 ± 1.62 | 91.78 ± 1.44 | 1.18 ± 0.00 | 0.68 ± 0.65 | ||
| – | – | ||||||||||||
| – | 04 | 70.00 ± 2.79 | 23.22 ± 1.51 | 95.42 ± 1.93 | 1.12 ± 0.04 | 0.93 ± 0.17 | |||||||
| 07 | 92.28*** ± 3.52 | 43.15 ± 1.33 | 93.30 ± 3.10 | 1.55 ± 0.04 | 1.77 ± 0.05 | 04 | 72.00 ± 4.45 | 23.45 ± 1.06 | 90.93 ± 2.61 | 1.06 ± 0.0 | 0.79 ± 0.29 | ||
| CC | 05 | 86.00*** ± 8.19 | 45.20 ± 2.78 | 83.94 ± 2.66b | 1.59 ± 0.22 | 1.66 ± 0.13 | 07 | 71.14 ± 2.84 | 23.02 ± 0.92 | 93.34*** ± 1.98 | 1.09 ± 0.04 | 0.76 ± 0.14 | |
| CT | 09 | 95.44*** ± 1.97 | 44.11 ± 1.22 | 100.37*** ± 0.52b/c | 1.62 ± 0.06 | 1.69 ± 0.03 | 03 | 77.33 ± 4.05 | 24.62 ± 1.04 | 91.85 ± 0.83 | 1.16 ± 0.01 | 0.98 ± 0.48 | |
| TT | 04 | 80.50 ± 9.07 | 45.19 ± 1.71 | 88.11 ± 4.15c | 1.68 ± 0.09 | 1.71 ± 0.16 | – | ||||||
***very highly significant (p = 0.000).
*significant (p < 0.05).
ANOVA followed by post-hoc Tukey, P - present, N - null.
a = 0.002.
b = 0.000.
c = 0.001.
Pearson correlation and univariate regression analyses of study characteristics with genetic damage, SOD activity and molecular genotypes.
| Study Characteristics | Pearson Correlation/Regression Coefficient | Damage Frequency | Mean DNA Migration Length | Total Antioxidant Capacity (TAC) | Malondialdehyde (MDA) Levels | Superoxide Dismutase (SOD) Activity |
|---|---|---|---|---|---|---|
| Age | r | 0.101 | −0.240 | −0.057 | −0.310 | 0.088 |
| β | 0.101 | −0.240 | −0.057 | −0.310 | 0.088 | |
| p | 0.611 | 0.219 | 0.772 | 0.109 | 0.656 | |
| Gender | r | 0.333 | 0.027 | 0.027 | 0.282 | −0.251 |
| β | 0.333 | 0.027 | 0.027 | 0.282 | −0.251 | |
| p | 0.083 | 0.893 | 0.893 | 0.146 | 0.198 | |
| Time-since-Excercising | r | 0.107 | −0.267 | −0.401 | −0.271 | 0.294 |
| β | 0.107 | −0.267 | −0.401 | −0.271 | 0.294 | |
| p | 0.674 | 0.284 | 0.099 | 0.277 | 0.237 | |
| Warm-up Time | r | 0.447 | −0.495 | −0.207 | −0.100 | −0.276 |
| β | 0.447 | −0.495 | −0.207 | −0.100 | −0.276 | |
| p | 0.063 | 0.411 | 0.693 | 0.267 | ||
| Diet | r | −0.058 | 0.209 | 0.149 | 0.060 | 0.143 |
| β | −0.058 | 0.209 | 0.149 | 0.060 | 0.143 | |
| p | 0.771 | 0.287 | 0.449 | 0.760 | 0.468 | |
| Body Mass Index | r | −0.027 | 0.275 | 0.178 | −0.073 | −0.026 |
| β | −0.027 | 0.275 | 0.178 | −0.073 | −0.026 | |
| p | 0.892 | 0.157 | 0.365 | 0.711 | 0.894 | |
| Waist Circumference | r | −0.558 | −0.910 | −0.703 | −0.807 | −0.037 |
| β | −0.558 | −0.910 | −0.703 | −0.807 | −0.037 | |
| p | 0.850 | |||||
| VO2 max | r | −0.053 | 0.381 | 0.225 | 0.104 | 0.081 |
| β | −0.053 | 0.381 | 0.225 | 0.104 | 0.081 | |
| p | 0.787 | 0.045 | 0.250 | 0.597 | 0.681 | |
| Mobile Phone Usage | r | 0.258 | 0.241 | 0.080 | 0.161 | 0.151 |
| β | 0.258 | 0.241 | 0.080 | 0.161 | 0.151 | |
| p | 0.184 | 0.216 | 0.686 | 0.412 | 0.443 | |
| r | −0.203 | −0.452 | −0.245 | −0.359 | 0.032 | |
| β | −0.203 | −0.452 | −0.245 | −0.359 | 0.032 | |
| p | 0.299 | 0.209 | 0.060 | 0.872 | ||
| r | 0.074 | −0.083 | 0.022 | −0.119 | −0.062 | |
| β | 0.074 | −0.083 | 0.022 | −0.119 | −0.062 | |
| p | 0.708 | 0.674 | 0.910 | 0.548 | 0.753 | |
| r | −0.203 | −0.185 | −0.086 | −0.120 | 0.130 | |
| β | −0.203 | −0.185 | −0.086 | −0.120 | 0.130 | |
| p | 0.301 | 0.347 | 0.665 | 0.543 | 0.511 |
p values in bold are statistically significant (p < 0.05).
Multivariate Regression Analyses of Study Characteristics and Molecular Genotypes of GST and SOD2 with VO2 max, Genetic Damage, SOD Activity, TAC and MDA Levels.
| Study Characteristics | Damage Frequency | Mean DNA Migration Length | SOD Activity | TAC Levels | Malondialdehyde Levels | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | t | p | β | t | p | β | t | p | β | t | p | β | t | p | |
| Age | 0.564 | 1.566 | 0.178 | 0.130 | 0.263 | 0.803 | 0.225 | 0.529 | 0.619 | 0.270 | 0.653 | 0.543 | 0.186 | 0.359 | 0.734 |
| Gender | 0.306 | 0.191 | 0.856 | 0.171 | 0.078 | 0.941 | 0.051 | 0.027 | 0.979 | −2.213 | −1.205 | 0.282 | 0.895 | 0.389 | 0.713 |
| Time-since-excercising | −0.283 | −0.647 | 0.546 | 0.331 | 0.552 | 0.605 | −0.097 | −0.188 | 0.858 | −0.416 | −0.828 | 0.445 | −0.790 | −1.257 | 0.264 |
| Warm-up time | 0.220 | 0.222 | 0.833 | −0.129 | −0.095 | 0.928 | −0.032 | −0.027 | 0.979 | 0.017 | 0.015 | 0.989 | −0.728 | −0.509 | 0.632 |
| VO2 max | −0.660 | −0.583 | 0.585 | 0.130 | 0.083 | 0.937 | 0.096 | 0.072 | 0.945 | −1.971 | −1.516 | 0.190 | 0.739 | 0.454 | 0.669 |
| Diet | −0.488 | −1.333 | 0.240 | −0.201 | −0.400 | 0.706 | 0.140 | 0.325 | 0.759 | −0.226 | −0.539 | 0.613 | −0.259 | −0.491 | 0.644 |
| Body Mass Index | 0.669 | 1.459 | 0.204 | 0.471 | 0.748 | 0.488 | −0.430 | −0.796 | 0.462 | 0.019 | 0.036 | 0.973 | −1.185 | −1.795 | 0.133 |
| Waist Circumference | −0.529 | −0.849 | 0.435 | 0.362 | 0.422 | 0.690 | −0.192 | −0.262 | 0.804 | 0.252 | 0.351 | 0.740 | 0.243 | 0.271 | 0.797 |
| Waist-Hip-Ratio | −0.029 | −0.065 | 0.951 | 0.040 | 0.065 | 0.951 | −0.916 | −1.730 | 0.144 | 0.646 | 1.251 | 0.266 | −0.505 | −0.781 | 0.470 |
| Mobile Phone Usage | 0.729 | 2.073 | 0.093 | 0.485 | 1.004 | 0.361 | 0.069 | 0.166 | 0.875 | −0.165 | −0.408 | 0.700 | 0.151 | 0.298 | 0.778 |
| −0.027 | −0.053 | 0.960 | 0.420 | 0.595 | 0.578 | −0.155 | −0.256 | 0.808 | 0.683 | 1.157 | 0.300 | −0.573 | −0.775 | 0.474 | |
| 0.107 | 0.296 | 0.779 | −0.287 | −0.578 | 0.589 | −0.422 | −0.988 | 0.369 | 0.812 | 1.950 | 0.109 | −0.565 | −1.084 | 0.328 | |
Comparison of factor loadings by principal component analysis with Varimax rotation and communalities of the study characteristics including DNA damage and molecular genotypes.
| Study Characteristics | Communalities | Factor 1 | Factor 2 | Factor 3 | Factor 4 | Factor 5 | Factor 6 |
|---|---|---|---|---|---|---|---|
| Age | 0.715 | −0.030 | −0.014 | 0.016 | −0.004 | 0.176 | |
| Time-since-excercising | 0.736 | 0.025 | 0.044 | 0.258 | 0.393 | ||
| Warm-up time | 0.877 | −0.188 | −0.101 | −0.009 | 0.177 | −0.075 | |
| Diet | 0.856 | 0.102 | 0.386 | 0.105 | 0.232 | −0.219 | |
| Body Mass Index | 0.636 | 0.257 | 0.162 | −0.077 | 0.147 | −0.110 | |
| Hip circumference | 0.839 | −0.090 | 0.139 | −0.264 | 0.042 | 0.111 | |
| Waist Circumference | 0.862 | −0.319 | −0.024 | −0.125 | 0.263 | ||
| Waist-Hip-Ratio | 0.908 | −0.340 | −0.297 | 0.268 | −0.002 | 0.069 | |
| Gender | 0.944 | 0.088 | 0.279 | −0.304 | 0.248 | −0.184 | |
| VO2 max | 0.884 | 0.110 | −0.127 | 0.346 | −0.185 | −0.050 | |
| Mobile phone usage | 0.750 | 0.456 | 0.145 | −0.125 | 0.176 | 0.274 | |
| Damage Frequency | 0.845 | −0.250 | 0.228 | 0.051 | 0.390 | −0.327 | |
| Mean DNA migration length | 0.873 | −0.246 | 0.003 | 0.101 | 0.440 | −0.050 | |
| Total Antioxidant Capacity | 0.678 | 0.137 | 0.199 | 0.230 | 0.099 | −0.164 | |
| Malondialdehyde Levels | 0.684 | 0.044 | 0.028 | 0.436 | −0.410 | −0.146 | |
| SOD Activity | 0.831 | 0.043 | −0.054 | −0.876 | 0.207 | 0.129 | 0.012 |
| 0.772 | 0.045 | 0.212 | −0.384 | −0.243 | −0.213 | −0.688 | |
| 0.948 | −0.026 | −0.092 | 0.059 | −0.074 | −0.009 | ||
| 0.948 | −0.026 | −0.092 | 0.059 | −0.074 | −0.009 | ||
| 5.48 | 3.2 | 2.23 | 1.97 | 1.41 | 1.27 | ||
| 28.86 | 16.88 | 11.74 | 10.37 | 7.46 | 6.69 | ||
| 28.86 | 45.74 | 57.49 | 67.86 | 75.33 | 82.02 | ||
Values in bold have factor loading ≥0.4.
Receiver operating characteristic (ROC) curve for genetic damage and oxidative stress indices.
| Studied Indices | AUC | P value | Sensitivity | Specificity |
|---|---|---|---|---|
| Damage Frequency | 0.864 | 100.00 | 77.78 | |
| Mean DNA Migration Length | 1.000 | 100.00 | 100.00 | |
| Total Antioxidant Capacity | 0.944 | 100.00 | 94.44 | |
| Malondialdehyde Levels | 0.953 | 90.00 | 88.89 | |
| Superoxide Dismutase Activity | 0.578 | 0.113 | 100.00 | 50.00 |
p values in bold are statistically significant (p < 0.05), AUC - Area under curve.
Fig. 1Receiver operating characteristic (ROC) curve for genetic damage and oxidative stress indices.